Literature DB >> 8724837

The role of subsets of CD4+ T cells in autoimmunity.

D Fowell1, F Powrie, A Saoudi, B Seddon, V Heath, D Mason.   

Abstract

It is generally considered that T cells which are reactive with self-antigens are effectively eliminated by two processes: clonal deletion and the induction of T cell anergy. More recently, it has been shown that some potentially autoreactive T cells remain unactivated because the self-antigens for which they are specific are not presented on competent antigen-presenting cells. All these mechanisms of self-tolerance may be regarded as passive in the sense that the autoreactive cells are either deleted or are intrinsically non-responsive. If this view of self-tolerance is adopted, then one would predict that rendering animals relatively lymphopoenic should not give rise to autoimmune disease. This prediction is not verified by experiment. Rats rendered relatively lymphopoenic by adult thymectomy followed by repeated low dose gamma-irradiation develop a high incidence of autoimmune diabetes. Furthermore, it has been shown that the reconstitution of these rats with a specific subset of CD4+ T cells from syngeneic donors prevents the development of this disease. The protective cells have the CD45RClow phenotype, they are resistant to adult thymectomy and the majority of them appear to be non-activated in the donor rats. In contrast, the CD45RChigh CD4+ subset does not provide protection from diabetes. Instead, on injection into athymic rats, it gives rise to pathological changes in a variety of organs: stomach, pancreas, liver, thyroid and lung. In addition, the CD45RClow CD4+ subset prevents these manifestations of autoimmunity in these circumstances. Recently, we have shown that CD4+ CD8- thymocytes are a highly potent source of cells that have the ability to control autoimmune diabetes in rats. It appears that the thymus has three distinct functions: positive selection; negative selection; and the generation of a population of cells that seem specialized for the control of autoimmunity.

Entities:  

Mesh:

Year:  1995        PMID: 8724837     DOI: 10.1002/9780470514849.ch12

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  6 in total

Review 1.  Anti-TNF antibody treatment of Crohn's disease.

Authors:  S J van Deventer
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Drug-induced lymphopenia: focus on CD4+ and CD8+ cells.

Authors:  P Gergely
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

3.  Antigen inhibition of collagen-induced arthritis is associated with up-regulation of IL-4 mRNA and induction of Ox40 on T cells in draining lymph nodes.

Authors:  L Mattsson; K Lundberg; E Mussener; A Jansson; H Erlandsson Harris; P Larsson
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

Review 4.  Metals and kidney autoimmunity.

Authors:  P E Bigazzi
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

5.  CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness.

Authors:  Ciriaco A Piccirillo; John J Letterio; Angela M Thornton; Rebecca S McHugh; Mizuko Mamura; Hidekazu Mizuhara; Ethan M Shevach
Journal:  J Exp Med       Date:  2002-07-15       Impact factor: 14.307

6.  Lack of graft-versus-host-like pathology in mercury-induced autoimmunity of Brown Norway rats.

Authors:  P E Bigazzi; L L Kosuda; M O Hannigan; B Whalen; D L Greiner
Journal:  Clin Immunol       Date:  2003-11       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.